This segment focuses on the research, development, and clinical trials of novel drug candidates for the treatment of various cancers. Key activities include identifying and validating drug targets, designing and synthesizing small molecule and antibody-based therapeutics, and conducting preclinical and clinical studies. Technologies employed include medicinal chemistry, molecular biology, and pharmacology. The primary therapeutic areas are non-Hodgkin lymphomas, acute myeloid leukemia, myelodysplastic syndromes, and advanced solid tumors. The goal is to improve patient outcomes by providing targeted therapies with improved efficacy and reduced side effects. Market positioning is based on developing innovative therapies, often in collaboration with other pharmaceutical companies. Future opportunities include expanding the pipeline with new drug candidates and expanding into new therapeutic areas. Regulatory and clinical aspects involve navigating FDA approval processes and conducting clinical trials. Partnerships with companies like F. Hoffmann-La Roche Ltd. and Genentech Inc. are crucial for commercialization.

This segment concentrates on developing therapies that harness the power of the immune system to fight cancer, as well as precision medicine approaches that target specific genetic alterations in tumors. Research and development activities include identifying and validating immune checkpoints, developing small molecule compounds, and conducting preclinical and clinical studies. Technologies used include immuno-oncology, genomics, and precision medicine. The therapeutic areas covered include advanced solid tumors and lymphomas. The patient impact is focused on providing more effective and personalized cancer treatments. Market positioning is based on developing innovative therapies, often in collaboration with other pharmaceutical companies. Future opportunities include expanding the pipeline with new drug candidates and expanding into new therapeutic areas. Regulatory and clinical aspects involve navigating FDA approval processes and conducting clinical trials. Partnerships with companies like Aurigene Discovery Technologies Limited are crucial for discovery, development, and commercialization.